Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
46.39Prev. Close
46.77Volume
1,33,668Total traded value
0.63 CrUpper Circuit
56.12Lower Circuit
37.41Fundamentals
| Market Cap | ₹258Cr |
| ROE | 10.82% |
| P/E Ratio(TTM) | 13.68 |
| EPS(TTM) | 3.42 |
| P/B Ratio | 1.11 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.60 |
| Book Value | 41.98 |
| Debt to Equity | 0.23 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Balaxi Pharma
Balaxi Pharma is a global pharmaceutical company making affordable generic and branded generic medicines accessible in frontier markets across Latin America and Africa. The company's purpose is to bring high-quality everyday medicines within reach of these populations, creating sustainable value for all stakeholders. It has an impressive portfolio with 960 registered products across multiple countries and is committed to expanding its market presence.;
| Parent Organisation | Balaxi Pharmaceuticals Limited |
| Managing Director | Mr. Ashish Maheshwari |
| NSE Symbol | BALAXI |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 104.06 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.19 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.19 | ||
| Wockhardt | NA (0.00%) | -198.91 |